Xiamen, China

Yi Guan

This inventor holds 1 USPTO granted patent. Top assignees: Xiamen University, Yang Sheng Tang Company Limited. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yi Guan. Retrieved from https://idiyas.com/inventor/yi-guan-so2rvcym

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yi Guan - Innovator in Avian Influenza Research

Introduction

Yi Guan is a prominent inventor based in Xiamen, China. He has made significant contributions to the field of avian influenza research, particularly through his innovative work on monoclonal antibodies.

Latest Patents

Yi Guan holds a patent for "Monoclonal antibodies binding to avian influenza virus subtype H5 haemagglutinin and uses thereof." This invention provides monoclonal antibodies that specifically bind to H5 subtype avian influenza virus hemagglutinin (HA) proteins. These antibodies can block the binding activity of at least 50% of known monoclonal antibodies to the H5 subtype avian influenza virus hemagglutinin (HA) protein. The monoclonal antibodies are applicable for the detection, diagnosis, prevention, and treatment of avian influenza viruses, especially the H5 subtype. The invention also includes related hybridoma cell lines, isolated nucleic acid molecules, short peptides, and medical compositions and diagnostic equipment containing the monoclonal antibody.

Career Highlights

Throughout his career, Yi Guan has worked with esteemed institutions such as Xiamen University and Yang Sheng Tang Company Limited. His research has significantly advanced the understanding and management of avian influenza.

Collaborations

Yi Guan has collaborated with notable colleagues, including Wenxin Luo and Ningshao Xia, contributing to the advancement of research in his field.

Conclusion

Yi Guan's innovative work in developing monoclonal antibodies for avian influenza has the potential to greatly impact public health. His contributions to research and collaboration with other experts highlight his importance in the scientific community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…